Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Yield10 Bioscience's operating assets for the quarter that ended in Jun. 2024 was $2.24 Mil. Yield10 Bioscience's operating liabilities for the quarter that ended in Jun. 2024 was $6.42 Mil. Yield10 Bioscience's Total Assets for the quarter that ended in Mar. 2024 was $4.24 Mil. Therefore, Yield10 Bioscience's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was -0.99.
Yield10 Bioscience Scaled Net Operating Assets Related Terms
Yield10 Bioscience Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Yield10 Bioscience's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yield10 Bioscience Scaled Net Operating Assets Chart
YTENQ vs GNVR, CTVA, CF: Scaled Net Operating Assets Comparison
For the Agricultural Inputs subindustry, Yield10 Bioscience's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yield10 Bioscience Scaled Net Operating Assets vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Yield10 Bioscience's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Yield10 Bioscience's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of -0.99 mean?
Yield10 Bioscience (YTENQ) has a Scaled Net Operating Assets of -0.99 as of Jun. 2024. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Yield10 Bioscience and its competitors.
Is Yield10 Bioscience's Scaled Net Operating Assets too high?
Yield10 Bioscience's current Scaled Net Operating Assets is -0.99. Overall, Yield10 Bioscience has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Yield10 Bioscience's Scaled Net Operating Assets compare to GNVR and CTVA?
Yield10 Bioscience's Scaled Net Operating Assets of -0.99 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for an Agriculture company?
A good Scaled Net Operating Assets depends on the Agriculture industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Yield10 Bioscience and its competitors. Yield10 Bioscience's current Scaled Net Operating Assets is -0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yield10 Bioscience stock overvalued right now?
Yield10 Bioscience (YTENQ) has a current Scaled Net Operating Assets of -0.99. The current Scaled Net Operating Assets is -0.99. Yield10 Bioscience's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Yield10 Bioscience (YTENQ), the current Scaled Net Operating Assets is -0.99 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yield10 Bioscience Inc is an agricultural bioscience company. It is leveraging advanced genetics to develop the oilseed Camelina sativa as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics.
16GF Score
Get the complete analysis for YTENQ
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YTENQ has been successfully added to your 
